However, rival ViiV Healthcare, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV's...
8 Feb 2018 4:24 AM GMT
Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.
30 April 2018 4:27 AM GMT
Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.
15 May 2020 6:16 AM GMT